ÂÜÀòÂÒÂ×

Jing Zhou serves as the President of Singleron Biotechnologies since March 2018, focusing on the research and development of high throughput single-cell analysis technologies and expanding the US market. Previously, Jing Zhou held the position of Vice President of Engineering at Singleron, overseeing microfluidics based single-cell analysis platforms for clinical applications. As a Review Editor for Frontiers in Bioengineering and Biotechnology, Jing Zhou certifies the validity of publications. Past experiences also include roles as a Patent Agent and Technology Specialist at Dilworth IP, Advisor to the CEO at IsoPlexis, Associate Research Scientist/Lecturer at Yale University, and Guest Research Associate at NIST. Jing Zhou completed a PhD and MS in Mechanical Engineering at the University of California, Berkeley, following a BS in Modern Mechanics from the University of Science and Technology of China.